No Compromise Immunoassays
One platform. Same answers independent of plex.
Ultrasensitive quantitation, absolute precision, and reproducibility — without trade-offs between sensitivity, multiplexing, or sample volume.
The Problem
Immunoassays shouldn’t force
trade-offs
Following screening researchers
still have to choose between:
Sensitivity vs Multiplexing
Do not trade one for the other. Get both
Dynamic Range vs Re-runs
Measure a wider range of sample concentrations with one dilution
Sample Volume vs Data Depth
Get more data from your precious samples by either using less/diluting it more
Flexibility vs Workflow Simplicity
Screen your own antibodies, Create custom plates from a menu, Choose from pre-validated plates
The Solution: No Compromise
A fundamentally different approach
PFLISA™ is built to remove compromise completely
- Same quantitation from singleplex to multiplex
- No platform switching as your assay evolves
- Ultrasensitivity at any plex
- Consistent results from discovery to clinical
One platform, across every stage & need
Benefits in Practice
See more, even low-abundance biology
● True femtogram level sensitivity
● Detect what ELISA misses
Use less - maximize precious samples
● ≤15 µL sample input
● High-plex without compromise
Do less rework & get answers faster
● 4–5 log dynamic range
● Fewer dilutions & reruns
Stay flexible - without disruption
● ELISA-like workflow
● One system: Homebrew & Multiplex
-
Researchers are using PFLISA™ to:
- Identify biomarkers earlier in discovery
- Simplify preclinical workflows
- Reduce assay complexity across teams
- Standardize data across stages
Stop compromising on your data !
What this means for your research
More data
Multiplex without compromise
Better data
Ultrasensitive quantitation
Deeper insight
Detect what others miss
Less sample
Preserve valuable material
No Compromise Immunoassays
A fully integrated platform
All delivered in a scalable, ELISA-like workflow with rapid assay development flexibility.